Figure 4.
Downregulation of miR-548a could reduce the sensitivity of NSCLC cells to cisplatin by upregulating NEIL2 expression. A: miR-548a was downregulated by exogenous miR-548a inhibitor. B: Downregulation of miR-548a could increase NEIL2 expression in NSCLC cells. C: Downregulation of miR-548a could increase IC50 value of NSCLC cells to cisplatin. D: Upregulation of miR-548a could decrease IC50 value of NSCLC cells to cisplatin. NC: negative control. *P<0.05.